Forian, Inc. (FORA) Company Value to Net Income

Forian Corporation - graphic logo of issuer FORA

Forian Inc. (FORA) relies on exclusive access to closed medical and business archives while strictly adhering to HIPAA standards. A steady cash flow coupled with low equipment costs ensures liquidity. This chart of financial quotes with the -13.30 indicator confirms market positions. Forian Inc. (FORA) is integrating AI into the processing of health data arrays, helping governments forecast disease outbreaks and reduce therapy costs.

Forian Inc. (FORA) P/E Multiple: for the period 07/04/2022 - 05/30/2026

Analytical breakdowns for Forian Inc (FORA)

- market price and analyst price targets:
Market Price forian.com|FORA - Price Target Chart
- market capitalization details:
Market Value Forian Inc.|FORA - Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Share Forian|FORA - Book Capitalization|Market Capitalization to Book Value Ratio forian.com|FORA - Aggregate Company Assets
- debt and solvency information:
Debt to Equity Ratio Forian Inc.|FORA - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital Forian Corporation|FORA - Company Aggregate Debts|Debts to Net Assets Forian Inc.|FORA - Company Long-Term Debt|Company Short-Term Indebtedness Forian|Quick Liquidity Indicator forian.com
- earnings and market multiples details:
FORA - Net Income|Company Profit Forecast Forian Inc.|FORA - P/E Multiple|Price to Expected Earnings Ratio Forian, Inc.|FORA - Price/Earnings to Growth Ratio|Company Value to EBITDA Forian Inc.|FORA - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Forian|FORA - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth forian.com|FORA - Earnings growth in current year|Projected earnings per share growth rate for next year Forian Inc.
Summary company analysis:Forian Inc.
Product sample of Forian Corporation

The P/E ratio determines the investment payback period via net income, serving as a filter against asset overvaluation. The current price-to-earnings valuation trend reflects market sensitivity to profitability, where the stability of Forian Inc. (FORA) is supported by a high share of recurring payments from corporate clients, which mitigate risks associated with strict medical data security controls.

Analysis of competing companies

Market Cap to Earnings RELX Inc. RELX|Price to Earnings Ratio CoStar (CSGP)|VRSK (Verisk Analytics) - Company Value to Net Income|P/E Multiple EFX (Equifax Corp)|Business Payback Period Gartner Group (IT)|TransUnion - P/E Multiple|FDS - P/E Multiple|Morningstar (MORN) - Price to Earnings Ratio|Price to Earnings Multiple GTM|Price to Earnings Ratio PL|CLVT: Company Value to Net Income|P/E Multiple INOD|Business Payback Period similarweb.com|Price to Earnings Ratio PDF Solutions PDFS|TTGT: Price to Earnings Multiple|Forrester Research Inc - P/E Multiple|FiscalNote, Inc. (NOTE) - Price to Earnings Ratio|DNB (Dun & Bradstreet) - Price to Earnings Ratio|MTTR - Business Payback Period|ZI (ZoomInfo Technologies, Inc.) - P/E Multiple